Valrane^™

What Valrane does

• Fractional technology leadershipEngineering and product leadership on a defined scope, for companies that need the judgment without the headcount.
• Technical due diligenceArchitecture, delivery capability, regulatory posture and team assessment for acquirers and investors.
• Product and platform strategyArchitecture direction, build-versus-buy, platform consolidation, and the roadmap that follows from them.
• Regulated software deliveryIEC 62304 and FDA execution, 510(k) support, and medical-device cybersecurity readiness.

Who it is for

Medical-device and MedTech companies bringing regulated software to market. Technology and engineering organizations scaling past the point their current structure supports. Investors and acquirers who need a technical read they can act on.

Background

Valrane is Adam Duncan. Twenty-two years in technical leadership, twelve of them in regulated medical devices, most recently at director level inside a global medical-device manufacturer — leading an international software organization of roughly one hundred people against a $25M budget, across surgical robotics and regulated device software deployed on 1,000+ systems in 31+ markets and supporting more than 100,000 procedures. Six 510(k) submissions. Medical-device cybersecurity and 524(b) readiness, M&A technical diligence and integration, and the operating-model work that makes engineering organizations predictable.

How to engage

• Advisory retainerOngoing fractional leadership against defined outcomes. Monthly.
• Scoped projectA fixed-fee assessment with an executive deliverable — platform, organization, or regulatory readiness.
• Diligence sprintA technical read on a target, delivered to a transaction timeline.